FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38499811000001103: Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-May 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1337351000001112 Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1337361000001110 Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Has specific active ingredient Esketamine hydrochloride true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Is a Esketamine 28mg/0.2ml nasal spray unit dose true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Is a Spravato true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Esketamine false Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Has specific active ingredient Esketamine hydrochloride false Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Esketamine false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) 2 unit dose 2 x 0.2ml unit doses Has AMP True Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) 1 unit dose 1 x 0.2ml unit doses Has AMP True Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) 3 unit dose 3 x 0.2ml unit doses Has AMP True Spravato 28mg/0.2ml nasal spray unit dose (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start